Blog
May 15, 2023
Poster sessions at AACR: a recap
We were grateful for the opportunity to attend and present at the AACR Annual Meeting last week, where three of our scientists highlighted some of the exciting work happening in our Vancouver lab.
The demand for access to less invasive biopsy methods for cancer presents a critical decision for many provider laboratories.
In this webinar, Mr. Brady Davis MBA and Dr. Anna Lapuk, outline the pros and cons for bringing plasma testing in-house vs. send out services for oncology testing, suggest when organizations might find the transition most beneficial, and outline the process for transitioning from send out to in-house testing.
Critical factors for consideration such as staffing, oncologist and pathologist outreach and education, LIMS and data ecosystem integration, and clinical reporting will be presented.
Recent Resources
Press
March 28, 2023
Imagia Canexia Health Announces Three Abstracts to be Presented at AACR Annual Meeting 2023 Highlighting the Company’s Latest Research Findings
Imagia Canexia Health announced that three abstracts highlighting the company’s new learnings and tools will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19, 2023, at the Orange County Convention Center in Orlando, Florida.
Webinar
March 27, 2023
Project ACTT Webinar
Project ACTT (Access to Cancer Testing and Treatment) in Response to COVID-19 was a joint effort led by Imagia Canexia Health and supported by Digital Supercluster and partner institutions.